FDA Must List Withheld Documents on Ebola Drug Access, Court Says

The FDA must produce a list of the documents it's withholding on access to the experimental Ebola drug ZMapp so a federal district court can decide whether any of them should be released ( Goldwater Inst. v. HHS, D. Ariz., No. 2:15-cv-01055-SRB, 6/16/16 ).

The court's June 16 ruling comes at a time of increased interest in the access to experimental drugs for use in both pandemics and to aid the dying. Continue…

More